Peptide catalog
Browse our peptide flyers
A visual catalog of the educational flyers we share in the office. For questions about any peptide, book a consultation with our provider.
Flyer files
Click a file to open it
- BPC-157BPC-157 — Investigational Research Peptide
- CagrilintideCagrilintide — Amylin Analog (Weight-Loss Research)
- CJC-1295/IpamorelinCJC-1295/Ipamorelin — Growth Hormone–Releasing Combination
- DIHEXADIHEXA — Investigational Neuroprotective Peptide
- EpitalonEpitalon — Telomerase & Longevity Research Peptide
- GHK-CuGHK-Cu — Copper-Binding Tripeptide
- GLOWGLOW — GHK-Cu, BPC-157 & TB-500 Combination
- IpamorelinIpamorelin — Growth Hormone Secretagogue
- KisspeptinKisspeptin — Reproductive Hormone Peptide
- KPVKPV — Investigational Tripeptide
- LL-37LL-37 — Human Cathelicidin (Host Defense Peptide)
- Melanotan IIMelanotan II — Melanocortin Analog
- MOTS-CMOTS-C — Mitochondrial-Derived Peptide
- NAD+NAD+ — Cellular Energy Coenzyme
- PT-141PT-141 — Bremelanotide (Melanocortin Agonist)
- SemaglutideSemaglutide — GLP-1 Receptor Agonist
- SermorelinSermorelin — Growth Hormone–Releasing Hormone Analog
- SLU-PP-332SLU-PP-332 — Preclinical Research Compound
- SNAP-8SNAP-8 — Cosmetic Anti-Wrinkle Peptide
- SS-31SS-31 — Mitochondria-Targeted Peptide
- TB-500TB-500 — Investigational Research Peptide
- TesamorelinTesamorelin — Growth Hormone–Releasing Factor Analog
- Thymosin Alpha-1Thymosin Alpha-1 — Immune-Modulating Peptide
- TirzepatideTirzepatide — Dual GIP + GLP-1 Receptor Agonist
- Triple Receptor AgonistTriple Receptor Agonist — What Current Research Is Exploring
- Wolverine BlendWolverine Blend — BPC-157 & TB-500 Recovery Combination
These flyers are general education and do not replace an evaluation with a licensed provider. Candidacy, dosing, and monitoring are decided during a consultation based on your history, goals, and laboratory results.
Ready when you are
Become a patient at Beyond Health
Schedule in-person care in Middlebury, Connecticut, or meet with us by telehealth from anywhere in the state.